Clinical Trials
2
Active:1
Completed:0
Trial Phases
2 Phases
Phase 1:1
Phase 4:1
Drug Approvals
3
EMA:2
CIMA_AEMPS:1
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 4
1 (50.0%)Double-blind, Placebo-controlled, Randomized Clinical Trial Comparing the Efficacy and Safety of Sialanar Plus orAl rehabiLitation Against Placebo Plus Oral Rehabilitation for chIldren and Adolescents With seVere Sialorrhoea and Neurodisabilties,
Phase 4
- Conditions
- SialorrheaNeurodevelopmental Disorders
- Interventions
- First Posted Date
- 2021-05-05
- Last Posted Date
- 2022-07-08
- Lead Sponsor
- Proveca Pharma Limited
- Target Recruit Count
- 80
- Registration Number
- NCT04873115
- Locations
- 🇫🇷
CHU Lille, Lille, France
News
No news found